Virtus ETF Advisers LLC Allakos Inc. Transaction History

Virtus ETF Advisers LLC

$206 Million
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$1.02 - $3.23 $1,924 - $6,095	-1,887 Reduced 6.42%	27,504 $34,000
Q4 2023 Feb 15, 2024	BUY	$1.72 - $3.18 $15,848 - $29,300	9,214 Added 45.67%	29,391 $80,000
Q3 2023 Nov 07, 2023	SELL	$2.13 - $5.55 $4,289 - $11,177	-2,014 Reduced 9.08%	20,177 $45,000
Q2 2023 Aug 14, 2023	BUY	$3.6 - $5.25 $27,921 - $40,719	7,756 Added 53.73%	22,191 $96,000
Q1 2023 May 15, 2023	SELL	$4.3 - $8.27 $23,847 - $45,865	-5,546 Reduced 27.76%	14,435 $64,000
Q4 2022 Feb 14, 2023	BUY	$5.66 - $8.42 $113,092 - $168,240	19,981 New	19,981 $168,000
Q2 2022 Aug 12, 2022	SELL	$2.6 - $6.14 $4,945 - $11,678	-1,902 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$5.08 - $9.81 $568 - $1,098	-112 Reduced 5.56%	1,902 $11,000
Q4 2021 Feb 14, 2022	SELL	$8.55 - $111.89 $2,787 - $36,476	-326 Reduced 13.93%	2,014 $20,000
Q3 2021 Nov 15, 2021	SELL	$76.53 - $110.43 $9,336 - $13,472	-122 Reduced 4.96%	2,340 $248,000
Q2 2021 Aug 10, 2021	SELL	$85.37 - $114.1 $1,536 - $2,053	-18 Reduced 0.73%	2,462 $210,000
Q1 2021 May 17, 2021	BUY	$109.73 - $153.66 $4,169 - $5,839	38 Added 1.56%	2,480 $285,000
Q4 2020 Feb 12, 2021	SELL	$79.58 - $152.45 $167,834 - $321,517	-2,109 Reduced 46.34%	2,442 $342,000
Q3 2020 Nov 13, 2020	SELL	$66.43 - $90.99 $40,389 - $55,321	-608 Reduced 11.79%	4,551 $371,000
Q2 2020 Aug 05, 2020	BUY	$44.04 - $80.69 $98,253 - $180,019	2,231 Added 76.2%	5,159 $371,000
Q1 2020 May 14, 2020	SELL	$44.49 - $93.39 $18,774 - $39,410	-422 Reduced 12.6%	2,928 $130,000
Q4 2019 Feb 13, 2020	SELL	$66.49 - $137.73 $176,397 - $365,397	-2,653 Reduced 44.19%	3,350 $319,000
Q3 2019 Nov 12, 2019	SELL	$31.0 - $89.73 $10,385 - $30,059	-335 Reduced 5.29%	6,003 $472,000
Q2 2019 Aug 13, 2019	BUY	$36.0 - $44.73 $68,436 - $85,031	1,901 Added 42.84%	6,338 $275,000
Q1 2019 May 14, 2019	SELL	$33.79 - $51.99 $19,496 - $29,998	-577 Reduced 11.51%	4,437 $180,000
Q4 2018 Feb 05, 2019	BUY	$31.59 - $62.65 $158,392 - $314,127	5,014 New	5,014 $262,000

Others Institutions Holding ALLK

# of Institutions

Shares Held

64.7M

Call Options Held

47.1K

Put Options Held

Bvf Inc San Francisco, CA

16.6M
Shares

$17.5 Million
0.34% of portfolio
Nea Management Company, LLC Timonium, MD

6.15M
Shares

$6.52 Million
0.31% of portfolio
Deep Track Capital, LP Greenwich, CT

5M
Shares

$5.3 Million
0.12% of portfolio
Vanguard Group Inc Valley Forge, PA

3.51M
Shares

$3.73 Million
0.0% of portfolio
Redmile Group, LLC San Francisco, CA

3.08M
Shares

$3.26 Million
0.13% of portfolio

View Full List

About Allakos Inc.

Ticker ALLK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,726,096
Market Cap $89.8M
Description
Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...

More about ALLK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtus ETF Advisers LLC with notifications on news.

Account